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 ABSTRACT 
 The purpose of this study was to develop a determin-
istic economic model to estimate the costs associated 
with (1) the component cost per case of hyperketone-
mia (HYK) and (2) the total cost per case of HYK 
when accounting for costs related to HYK-attributed 
diseases. Data from current literature was used to 
model the incidence and risks of HYK (defined as a 
blood β-hydroxybutyrate concentration ≥1.2 mmol/L), 
displaced abomasa (DA), metritis, disease associations, 
milk production, culling, and reproductive outcomes. 
The component cost of HYK was estimated based 
on 1,000 calvings per year; the incidence of HYK in 
primiparous and multiparous animals; the percent of 
animals receiving clinical treatment; the direct costs of 
diagnostics, therapeutics, labor, and death loss; and the 
indirect costs of future milk production losses, future 
culling losses, and reproduction losses. Costs attribut-
able to DA and metritis were estimated based on the 
incidence of each disease in the first 30 DIM; the num-
ber of cases of each disease attributable to HYK; the 
direct costs of diagnostics, therapeutics, discarded milk 
during treatment and the withdrawal period, veteri-
nary service (DA only), and death loss; and the indirect 
costs of future milk production losses, future culling 
losses, and reproduction losses. The component cost 
per case of HYK was estimated at $134 and $111 for 
primiparous and multiparous animals, respectively; the 
average component cost per case of HYK was estimated 
to be $117. Thirty-four percent of the component cost 
of HYK was due to future reproductive losses, 26% to 
death loss, 26% to future milk production losses, 8% to 
future culling losses, 3% to therapeutics, 2% to labor, 
and 1% to diagnostics. The total cost per case of HYK 
was estimated at $375 and $256 for primiparous and 
multiparous animals, respectively; the average total 
cost per case of HYK was $289. Forty-one percent of 
the total cost of HYK was due to the component cost 
of HYK, 33% to costs attributable to metritis, and 
26% to costs attributable to DA. The high total cost of 
HYK at reported incidences of 40 to 60% highlights the 
importance of appropriate transition cow nutrition and 
management to decrease the effect of HYK. 
 Key words:   dairy cow ,  hyperketonemia ,  component 
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 INTRODUCTION 
 Negative energy balance occurs in early lactation 
dairy cattle when energy expenditure due to milk pro-
duction exceeds that available via feed intake (Bau-
man and Currie, 1980; Grummer, 1995; Herdt, 2000). 
Production of NEFA and ketone bodies (e.g., BHBA), 
which act as alternate fuel sources, are normal sequelae 
to negative energy balance adaptation, and thus cer-
tain circulating concentrations of these negative energy 
metabolites in the blood are normal during this stage 
of lactation. However, excessive production of NEFA 
and BHBA are indicative of a poor adaptive response 
to negative energy balance, and numerous studies have 
reported on the detrimental effects of elevated NEFA 
and BHBA on early lactation immune function (Ham-
mon et al., 2006; Contreras et al., 2010; Ster et al., 
2012), milk production (Duffield et al., 2009; Ospina 
et al., 2010a; Chapinal et al., 2012), and subsequent 
negative health events (Ospina et al., 2010b; Chapinal 
et al., 2011; Seifi et al., 2011). 
 Due to ease of measurement and quantification, the 
negative effects of elevated blood BHBA concentrations 
and resulting diagnosis of hyperketonemia (HYK; 
BHBA ≥1.2 mmol/L) are better documented than 
those for elevated blood NEFA concentrations (McArt 
et al., 2013; Ospina et al., 2013). Although the incidence 
of HYK in early lactation has been reported to range 
from 40 to 60% (Duffield et al., 1998; McArt et al., 
2012), there are few published reports on the economic 
effect of HYK. Although not the main objective of their 
studies, Duffield (2000) and Geishauser et al. (2001) 
estimated the cost per case of HYK between Canadian 
$50 and $100 and US$78, respectively. In general, one 
reason for the variation in disease cost estimates is the 
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inclusion of different components or inputs in each esti-
mate, which can lead to an over- or underestimation of 
the cost of disease.
Although the cost of HYK as ascribed to direct 
consequences of the effect of this condition on milk 
production, treatment, and culling (reported here as 
the component cost) is important, so is the cost of 
other diseases attributed to HYK (i.e., the increase in 
disease risk associated with HYK). The total cost of 
HYK, the sum of the component cost and additional 
disease-attributed costs, can then be used to estimate 
the economic effect of HYK and the financial benefits 
behind improved management and prevention of HYK. 
However, summation of the total cost of multiple 
diseases can overestimate the economic effect when 
multiple disease events are considered. For example, if 
an early lactation dairy cow develops HYK, metritis, 
and a displaced abomasum (DA), summation of the 
total costs of HYK, metritis, and a DA might involve 
double counting of certain costs (e.g., accounting for 
DA costs on a DA-disease basis as well as attribut-
ing costs associated with DA development associated 
with HYK). This leads to an overestimation of the 
economic health consequences of multiple diseases in 
a cow. To prevent this double counting, summation of 
the individual component costs of HYK, metritis, and 
DA allows for a more accurate economic estimate of the 
economic consequences of multiple disease occurrences. 
The objective of the current study was to use a deter-
ministic model to estimate the costs associated with (1) 
the component cost per case of HYK and (2) the total 
cost per case of HYK when accounting for the costs 
related to HYK-attributable DA and metritis cases.
MATERIALS AND METHODS
Model Inputs
Model input variables and values used to estimate the 
component cost of HYK are presented in Table 1. The 
marginal milk value was calculated using a feed price 
per unit of DM (lactating cow TMR) of $0.33 per kg 
(St-Pierre and Cobanov, 2014; www.sesamesoft.com), 
an energy density of feed (NEL per unit of feed) of 1.72 
per kg (NRC, 2001), megacalories of NEL required per 
unit of marginal milk of 0.70 per kg (NRC, 2001), and a 
milk price of $0.53 per kg (USDA National Agricultural 
Statistics Service, 2014). The total cost of HYK was 
estimated using the model inputs for the component 
cost of HYK as well as the DA (Table 2) and metritis 
(Table 3) costs attributable to HYK. Mastitis was not 
used in calculating costs attributable to HYK, as cur-
rent literature does not provide robust estimates of the 
magnitude of the effect of its association with HYK; the 
costs associated with retained placenta are represented 
within the cost of metritis. Risk ratios (RR) used to cal-
culate input values associated with culling, death, DA 
and metritis development, pregnancy to first service, 
and ovarian dysfunction in Table 1, Table 2, and Table 
3 are as follows: herd removal rate in the first 30 DIM = 
6.0% for primiparous animals and 6.3% for multiparous 
animals; percent of herd removals in the first 30 DIM 
due to death = 45% (McArt et al., 2012; J. McArt, D. 
Nydam, and G. Oetzel, University of Wisconsin, Mad-
sion; unpublished data); RR of culling in animals with 
HYK in the first 30 DIM versus non-HYK animals = 
1.8 (McArt et al., 2012; Roberts et al., 2012); RR of 
culling in animals developing HYK in the first week 
of lactation versus the second week of lactation = 4.5 
(McArt et al., 2012); RR of DA development in animals 
with HYK versus non-HYK animals = 8.0 (LeBlanc et 
al., 2005; Duffield et al., 2009; McArt et al., 2012); RR 
of metritis development in animals with HYK versus 
non-HYK animals = 3.3 (Duffield et al., 2009; Ospina 
et al., 2010b); RR of ovarian dysfunction in animals 
with HYK versus non-HYK animals = 5 (Dohoo and 
Martin, 1984; Hooijer et al., 2001; López-Gatius, 2003); 
and RR of pregnancy to first service in animals with 
HYK versus non-HYK animals = 0.8 (Walsh et al., 
2007). Items listed in tables concerning medication use, 
route of administration, dosage, and number of treat-
ments are not treatment recommendations but meant 
to reflect commonly used and literature-supported 
treatment protocols used on dairies.
Model Development
A deterministic partial budget model to estimate the 
component and total costs of HYK was developed us-
ing Excel (Microsoft, Redmond, WA). The component 
cost of HYK refers to the sum of costs associated with 
HYK alone, whereas the total cost of HYK refers to 
the sum of the component cost and the costs associ-
ated with diseases attributable to HYK (i.e., DA and 
metritis). The component cost of HYK was estimated 
based on 1,000 calvings per year; the incidence of 
HYK in primiparous and multiparous animals (BHBA 
≥1.2 mmol/L); the percent of animals receiving clini-
cal treatment; the direct costs of diagnostics (the cost 
for confirmation and retesting of cases across all HYK 
animals), therapeutics, labor, and death loss; and the 
indirect costs of future milk production losses, future 
culling losses, and reproduction losses. The total cost of 
HYK was estimated by summing the component cost of 
HYK plus costs attributable to DA and metritis, which 
were estimated based on the incidence of each disease 
in the first 30 DIM; the number of cases of each disease 
attributable to HYK; the direct costs of diagnostics, 
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Table 1. Deterministic model inputs to estimate the component cost per case of hyperketonemia (HYK) in early lactation dairy cattle 
Input variable Measure
Calvings per year (no.)  
 Animals calving per year 1,000
 Animal calving per year, LACT1 = 1 350
 Animals calving per year, LACT >1 650
Incidence of HYK (%)  
 BHBA ≥1.2 mmol/L, LACT = 1 252
 BHBA ≥1.2 mmol/L, LACT >1 352
 Receiving clinical treatment (BHBA ≥3.0 mmol/L), LACT = 1 52
 Receiving clinical treatment (BHBA ≥3.0 mmol/L), LACT >1 72
Diagnostics for clinical cases  
 BHBA strip cost ($) 1.75
 Syringe and needle cost for blood collection ($) 0.32
 Labor required for BHBA testing (min) 5 
Therapeutics for clinical cases  
 Intravenous 50% dextrose cost (1 bottle; $) 2.25
 Days of dextrose 23
 Needle and intravenous simplex cost for dextrose administration ($) 0.64
 Labor required for dextrose administrations (min) 10 
 Propylene glycol cost (300 mL; $) 1.98
 Days of propylene glycol 52
 Labor required for propylene glycol administration (min) 5
 Vitamin B12/butophosphan (25 mL, 0.05 mg of vitamin B12 and 100 mg of butaphosphan/mL; $) 4.00
 Number of days of vitamin B12/butophosphan 2
4
 Syringe and needle cost for vitamin B12/butophosphan administration ($) 0.64
 Labor required for vitamin B12/butophosphan administration (min) 3 
 Expected markup of drugs and supplies (%) 5
Labor  
 Cost per hour ($) 15.00
Death loss (1–30 DIM)  
 Animals that die due to HYK, LACT = 1 (no.) 1.65
 Animals that die due to HYK, LACT >1 (no.) 4.15
 Average value animal, LACT = 1 ($) 1,9006
 Average value animal, LACT >1 ($) 1,541
 Disposal cost for dead animal ($) 100
Future milk production losses  
 Average milk loss per case, LACT = 1 (kg) 772
 Average milk loss per case, LACT >1 (kg) 772
 Marginal milk value ($/kg) 0.40
Future culling losses  
 Animals sold due to HYK, LACT = 1 (no.) 1.92
 Animals sold due to HYK, LACT >1 (no.) 5.02
 Average BW, LACT = 1 (kg) 545 
 Average BW, LACT >1 (kg) 682 
 Market value of animal, LACT = 1 ($) 1,0807
 Market value of animal, LACT >1 ($) 1,3507
 Hauling cost to market for cull animals ($) 60
Reproduction losses  
 Decrease in 1st service pregnancy per AI (%) 258
 Baseline overall 21-d pregnancy rate (%) 18
 Feed cost ($/kg) 0.29
 Replacement cost ($) 1,9006
 Cull cow price ($/kg) 1.987
 Animals with ovarian dysfunction attributable to HYK, LACT = 1 (no.) 149
 Animals with ovarian dysfunction attributable to HYK, LACT >1 (no.) 309
 Veterinary professional fee per hour ($) 120
 Veterinary time required for diagnosis of ovarian dysfunction (min) 2
 Veterinary service call fee ($) 45
 Progesterone insert ($) 9.98
 Labor required to administer progesterone insert (min) 5
1LACT = lactation.
2McArt et al. (2012).
3Wagner and Schimek (2010); Gordon et al. (2013).
4Rollin et al. (2010); Gordon et al. (2012).
5McArt et al. (2012); Roberts et al. (2012).
6Replacement heifer prices calculated from USDA, Agriculture Marketing Service (2014).
7Cull cow prices calculated from USDA, Agriculture Marketing Service (2014).
8Walsh et al. (2007).
9Dohoo and Martin (1984); Ijaz et al. (1987); Hooijer et al. (2001); López-Gatius (2003).
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Table 2. Deterministic model inputs to estimate the displaced abomasum (DA) costs attributable to hyperketonemia (HYK) in early lactation 
dairy cattle 
Input variable Measure
Incidence of DA  
 Incidence of DA in first 30 DIM (%) 51
 DA cases attributable to HYK, LACT2 = 1 (no.) 163
 DA cases attributable to HYK, LACT >1 (no.) 243
Diagnostics  
 Labor required for DA diagnosis (part of normal on-farm fresh cow monitoring; min) 0
Therapeutics  
 Intravenous 50% dextrose cost (1 bottle; $) 2.25
 Days of dextrose 24
 Needle and intravenous simplex cost for dextrose administration ($) 0.64
 Labor required for dextrose administrations (min) 10
 Propylene glycol cost (300 mL; $) 1.98
 Days of propylene glycol 55
 Labor required for propylene glycol administrations (min) 5
 Vitamin B12/butophosphan (25 mL, 0.05 mg of vitamin B12, and 100 mg of butaphosphan/mL; $) 4.00
 Days of vitamin B12/butophosphan 2
6
 Syringe and needle cost for vitamin B12/butophosphan administration ($) 0.64
 Labor required for vitamin B12/butophosphan administration (min) 3 
 Flunixin meglumine, LACT = 1 (12 mL, 50 mg/mL; $) 1.68
 Flunixin meglumine, LACT >1 (15 mL, 50 mg/mL; $) 2.10
 Days of flunixin meglumine 2
 Syringe and needle cost for flunixin meglumine administration ($) 0.64
 Labor required for intravenous flunixin meglumine administration (min) 15
 Ampicillin, LACT = 1 (24 mL, 400 mg/mL; $) 8.64
 Ampicillin, LACT >1 (30 mL, 400 mg/mL; $) 10.80
 Days of ampicillin 4
 Syringe and needle cost for ampicillin administration ($) 1.28
 Labor required for ampicillin administration (min) 3
 Oral fluids/drench (0.7 kg of Ca propionate, 200 g of MgSO4, 100 g of KCl; $)
7 4.00
 Days of oral fluids/drench 1
 Labor required for oral fluids/drench (min) 15
 Laparotomy ($) 145
Discarded milk during treatment and the withdrawal period  
 Marginal milk value ($/kg) 0.40
 Value of discarded milk per day, LACT = 1 (fed to calves; $) 1.80
 Value of discarded milk per day, LACT >1 (fed to calves; $) 2.70
 Days milk is discarded (48 h after last dose of ampicillin) 6
Veterinary service  
 Veterinary time required to diagnose DA (min) 15 
Death loss (1–30 DIM)  
 DA cases attributable to HYK that die or are condemned with no value, LACT = 1 (n) 18
 DA cases attributable to HYK that die or are condemned with no value, LACT >1 (n) 38
Future milk production losses  
 Days with reduced milk production 1009
 Average decrease in milk production per day (kg) 1.79
Future culling losses (no.)  
 DA cases attributable to HYK culled in the first 30 DIM, LACT = 1 18
 DA cases attributable to HYK culled in the second 30 DIM, LACT = 1 38
 DA cases attributable to HYK culled in the first 30 DIM, LACT >1 28
 DA cases attributable to HYK culled in the second 30 DIM, LACT >1 58
Reproduction losses  
 Delay to first service (d) 129
1Shaver (1997).
2LACT = lactation.
3LeBlanc et al. (2005); Duffield et al. (2009); McArt et al. (2012).
4Wagner and Schimek (2010); Gordon et al. (2013).
5McArt et al. (2012).
6Rollin et al. (2010); Gordon et al. (2012).
7Stokes and Goff (2001).
8Sterner et al. (2008).
9Raizman and Santos (2002).
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therapeutics, discarded milk during treatment and the 
withdrawal period (modeled based on feeding of waste 
milk to calves), veterinary service (DA only), and death 
loss; and the indirect costs of future milk production 
loses, future culling losses, and reproduction losses. In 
total, 88% of DA cases and 70% of metritis cases were 
attributed to HYK. These percentages were calculated 
using the underlying RR of DA and metritis develop-
ment in HYK animals listed previously, an average 
HYK incidence across parities of 32%, a DA incidence 
of 5%, and an average metritis incidence across parities 
of 18.5%. A 2 by 2 table used to calculate the per-
Table 3. Deterministic model inputs to estimate the metritis costs attributable to hyperketonemia (HYK) in 
early lactation dairy cattle 
Input variable Measure
Incidence of metritis  
 Incidence of metritis in first 30 DIM, LACT1 = 1 (%) 20
 Incidence of metritis in first 30 DIM, LACT >1 (%) 10
 Incidence of toxic metritis in first 30 DIM (%) 5
 Cases of metritis attributable to HYK, LACT = 1 (no.) 322
 Cases of metritis attributable to HYK, LACT >1 (no.) 432
Diagnostic  
 Labor required for metritis diagnosis (part of normal on-farm fresh cow monitoring; min) 0
Therapeutics for metritis  
 Ceftiofur crystalline free acid, LACT = 1 (18 mL, 200 mg/mL; $) 30.24
 Ceftiofur crystalline free acid, LACT >1 (22.5 mL, 200 mg/mL; $) 37.80
 Ceftiofur crystalline free acid treatments (no.) 2
 Syringe and needle cost for ceftiofur crystalline free acid administration ($) 0.64
 Labor required for ceftiofur crystalline free acid administration (min) 15
Therapeutics for toxic metritis  
 Flunixin meglumine, LACT = 1 (12 mL, 50 mg/mL; $) 1.68
 Flunixin meglumine, LACT >1 (15 mL, 50 mg/mL; $) 2.10
 Days of flunixin meglumine 2
 Syringe and needle cost for flunixin meglumine administration ($) 0.64
 Labor required for intravenous flunixin meglumine administration (min) 15
 Ampicillin, LACT = 1 (24 mL, 400 mg/mL; $) 8.64
 Ampicillin, LACT >1 (30 mL, 400 mg/mL; $) 10.80
 Days of ampicillin 4
 Syringe and needle cost for ampicillin administration ($) 1.28
 Labor required for ampicillin administration (min) 3
 Calcium bolus (43 g of calcium; $) 5.58
 Number of calcium bolus treatments 23
 Labor required for calcium bolus (min) 5
 Intravenous hypertonic saline (2 L, 7–7.5% solution; $) 7.88
 Doses of intravenous hypertonic saline (no.) 1
 Syringe and needle cost for administration of intravenous hypertonic saline ($) 0.32
 Labor required for intravenous hypertonic saline (min) 10
 Oral fluids/drench4 (0.7 kg of Ca propionate, 200 g of MgSO4, 100 g of KCl; $) 4.00
 Days of oral fluids/drench 1
 Labor required for oral fluids/drench (min) 15
Discarded milk during treatment and the withdrawal period  
 Value of discarded milk per day, LACT = 1 (fed to calves; $) 1.80
 Value of discarded milk per day, LACT >1 (fed to calves; $) 2.70
 Days milk is discarded (48 h after last dose of ampicillin) 6
Death loss (1–30 DIM) due to toxic metritis (no.)  
 Metritis cases attributable to HYK that die, LACT = 1 15
 Metritis cases attributable to HYK that die, LACT >1 25
Future milk production losses (kg)  
 Average decrease in milk production from 1 to 30 DIM 6.95
 Average decrease in milk production from 31 to 60 DIM 4.15
 Average decrease in milk production past 60 DIM 2.75
Future culling losses (no.)  
 Metritis cases attributable to HYK that are culled, LACT = 1 25
 Metritis cases attributable to HYK that are culled, LACT >1 25
Reproduction losses (%)  
 Decrease in 21-d pregnancy rate (e.g., 18 to 14%) 45
1LACT = lactation.
2Duffield et al. (2009); Ospina et al. (2010b).
3Oetzel and Miller (2012).
4Stokes and Goff (2001).
5Overton and Fetrow (2008).
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centage of DA cases attributable to HYK (Table 4) 
was developed using the previously mentioned val-
ues. The risk of DA development in an HYK animal 
(Risk DAHYK) was calculated from Table 4 to be 12.5%; 
the risk of DA development in a non-HYK animal 
(Risk DAN) was calculated to be 1.5%. The attribut-
able risk of DA to HYK (the percent of disease in the 
exposed population attributable to exposure) was then 
calculated as
(Risk DAHYK – Risk DAN)/(Risk DAHYK) = 0.88.
Thus, 88% of DA cases were attributed to HYK. The 
percentage of metritis cases attributable to HYK were 
calculated in the same manner using Table 5, which 
resulted in a risk of metritis development in an HYK 
animal (Risk METHYK) of 35.3% and a risk of metritis 
development in a non-HYK animal (Risk METN) of 
10.6%. The attributable risk of metritis to HYK was 
then calculated as
(Risk METHYK – Risk METN)/(Risk METHYK) = 0.70.
Metritis and DA costs attributable to HYK were then 
calculated by multiplying each cost by the incidence 
of the disease in HYK animals and the percentage of 
disease cases attributed to HYK.
To account for variation in HYK, DA, and metritis 
incidence across farms, the average total cost per case 
of HYK was modeled at 3 different incidences for each 
disease; each input variable was adjusted singularly 
with all others remaining constant to assess the effect 
of a 50% reduction and a 50% increase in the incidence 
of each disease. As current market values for the price 
of milk, cost of feed, and market cow price are high 
compared with historic values, each of these variables 
was singularly adjusted in the model with all other 
variables held constant to assess the effect of a 20 and 
40% reduction in price on the average total cost per 
case of HYK. Graphs to illustrate the effect of varia-
tions in HYK, DA, and metritis incidence and price of 
milk, cost of feed, and market cow price on the average 
total cost per case of HYK were developed using Excel 
(Microsoft).
RESULTS AND DISCUSSION
Deterministic modeling was conducted to estimate 
the component and total costs per case of HYK. Models 
were developed with the assumption that 35% of calv-
ings were from primiparous cows. Twenty-five percent 
of primiparous cows and 35% of multiparous cows were 
assumed to develop HYK (BHBA ≥1.2 mmol/L), and 
20% of HYK-positive animals were assumed to develop 
clinical ketosis (BHBA ≥3.0 mmol/L).
The component cost per case of HYK was estimated 
at $134 and $111 for primiparous and multiparous ani-
mals, respectively; the average component cost per case 
of HYK was estimated to be $117 (Table 6). As the 
average component cost per case was modeled using an 
assumption of 35% primiparous calvings, a herd with a 
higher percentage of primiparous calvings would have 
an increased component cost per case. The difference 
in cost between primiparous versus multiparous cows is 
primarily due to a higher animal value for first-lactation 
animals when considering the direct cost of death loss 
as well as the increase in lost value to the herd when 
considering the indirect cost of future culling losses. As 
the partial costs of death loss and future culling losses 
account for 34% of the component cost of HYK in an 
average case (Figure 1), herds with a higher proportion 
of first-lactation animals will incur larger total long-
term financial repercussions than herds with more mul-
tiparous animals. This model also highlights the minor 
contribution of labor, diagnostics, and therapeutics, 
which account for only 6% of the component cost per 
case of HYK. As an example, this study provides infor-
mation based on commonly used on-farm HYK treat-
ments, and some herds may use more or less expensive 
treatment protocols. If no therapeutic treatments were 
given for HYK cases in a herd, the average component 
cost per case would only decrease from $117 to $114.
The component costs of DA and metritis necessary to 
calculate the costs attributable to HYK are presented 
in Table 7 and 8, respectively, with an average com-
ponent cost of $707 per DA case and $396 per case of 
metritis. These costs were used to calculate the disease 
Table 4. Percentage of displaced abomasa (DA) cases attributable to 
hyperketonemia in early lactation dairy cattle1  
Item (%) DA No DA Total
Hyperketonemia 40 280 320
No hyperketonemia 10 670 680
Total 50 950 1,000
1Use of this information to calculate the attributable risk resulted in 
88% of DA cases in hyperketonemic cows being attributed to hyper-
ketonemia.
Table 5. Percentage of metritis (MET) cases attributable to 
hyperketonemia in early lactation dairy cattle1  
Item (%) MET No MET Total
Hyperketonemia 113 207 320
No hyperketonemia 72 608 680
Total 185 815 1,000
1Use of this information to calculate the attributable risk resulted 
in 70% of metritis cases in hyperketonemic cows being attributed to 
hyperketonemia.
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specific costs attributable to HYK used in Table 9. For 
example, as the component cost of a DA was calculated 
to be $707, with an incidence of DA in HYK animals 
of 12.5% and 88% of DA cases attributed to HYK, the 
average DA cost attributed to HYK was estimated to 
be $76. Similar to the component cost of HYK, first-
lactation animals have higher DA costs attributable to 
HYK primarily due to death loss and future culling 
losses. Additionally, primiparous cows are at a higher 
risk for DA due to HYK than multiparous cows (McArt 
et al., 2012; J. McArt, D. Nydam, and G. Oetzel, Uni-
versity of Wisconsin, Madsion; unpublished data); thus 
the cost for therapeutics, discarded milk, veterinary 
service, labor, and future milk production and repro-
duction losses are slightly higher than for multiparous 
animals. The total cost of metritis attributable to HYK 
was almost twice as much for primiparous than mul-
tiparous cows due mainly to cost of therapeutics as 
well as future milk production, culling, and reproduc-
tion losses. As first-lactation animals are at a higher 
risk for metritis, they have higher treatment costs and 
costs due to the metritis-associated complications of 
reduced milk production, increased culling, and poor 
reproduction, on average, because of a higher incidence 
of metritis in the population.
Previously reported estimates of the cost per DA 
case stem from work described by Guard (2008). An 
estimate of $498 per DA case was calculated when the 
percent death per case, percent culled per case, milk 
not produced, milk discarded, extra days open, farm 
labor, veterinary service, and drug costs were taken 
into account (C. Guard, Cornell University, Ithaca, 
NY; personal communication, 2012). The main cost 
discrepancy between these 2 calculations result from 
a lower cost per dead cow and a lower cost associated 
with veterinary service and drug costs used in the 
Guard (2008) estimation. As it is unclear where input 
values were attained, further investigation is limited. 
The cost per case of metritis has previously been de-
scribed by Bartlett et al. (1986) as $106 per case ($230 
when adjusted for inflation; US Department of Labor, 
2014). However, no economic effect from milk loss was 
included in the calculation and a low overall culling risk 
was used. These differences may explain the approxi-
mately $150 difference in estimations of the component 
cost per case of metritis.
Table 6. Estimated component cost per case of hyperketonemia (blood BHBA ≥1.2 mmol/L) in early lactation 
dairy cattle (totals may differ from sum of costs due to rounding) 
Item ($)
Cost per case,  
LACT1 = 1
Cost per case,  
LACT >1
Average cost  
per case
Direct cost of hyperketonemia
 Diagnostic (1)2 (1) (1)
 Therapeutic (3) (3) (3)
 Discarded milk 0 0 0
 Veterinary service 0 0 0
 Labor (2) (2) (2)
 Death loss (36) (29) (31)
Indirect cost of hyperketonemia
 Future milk production losses (30) (30) (30)
 Future culling losses (19) (5) (9)
 Reproduction losses (41) (39) (40)
 Total (134) (111) (117)
1LACT = lactation.
2Parentheses denote a negative value.
Figure 1. Pie chart showing the percent contribution of each direct 
and indirect cost for the average case component cost of hyperketone-
mia. Repro = reproduction.
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The time sequence regarding diagnosis of HYK and 
subsequent DA development has been well reported 
(Geishauser et al., 1997; LeBlanc et al., 2005; Duffield 
et al., 2009); however, debate exists over the relation-
ship between HYK and metritis, as the 2 diseases often 
occur at similar time points in early lactation. In both 
Duffield et al. (2009) and Ospina et al. (2010b), where 
the investigators were careful to only attribute metritis 
that occurred after HYK diagnosis, an increase in the 
odds or risk of subsequent metritis diagnosis was re-
ported; however, a study by Chapinal et al. (2011) found 
no association between these 2 diseases. Although it is 
apparent that not all cases of metritis are related to 
HYK, attributing a certain proportion of metritis cases 
to HYK is within reason. The attribution of metritis 
and DA cases to HYK does not directly infer a cause 
and effect relationship; more likely a common preceding 
physiologic issue, for example a reduction in prepartum 
DMI (Huzzey et al., 2007; Goldhawk et al., 2009), is 
contributing to the development of these diseases. The 
presence of HYK merely explains the occurrence of a 
large proportion of the attributed diseases.
The total cost per case of HYK was estimated at 
$375 and $256 for primiparous and multiparous ani-
mals, respectively; the average total cost per case of 
HYK was $289 (Table 8). A pie chart showing the per-
cent contribution to the total cost per case of HYK of 
the component cost of HYK and the DA and metritis 
costs attributable to HYK is presented in Figure 2. 
Two other studies have estimated the cost of HYK, 
although less extensively than the reported modeling 
exercise. Duffield (2000) approximated the cost per 
case of HYK (BHBA ≥1.4 mmol/L) to be Canadian 
$50 to $100 when accounting for the treatment, pro-
duction, and culling costs associated with DA, clinical 
ketosis, and multiple illness (an animal having more 
than 1 of retained placenta, milk fever, metritis, en-
dometritis, mastitis, ketosis, DA, digestive, lameness, 
respiratory, or other disease) attributed to cows with 
HYK. Geishauser et al. (2001) calculated the cost per 
Table 7. Estimated component cost per case of displaced abomasum (totals may differ from sum of costs due 
to rounding) 
Item ($)
Cost per case,  
LACT1 = 1
Cost per case,  
LACT >1
Average cost  
per case
Direct cost of displaced abomasum    
 Diagnostic 0 0 0
 Therapeutic (212)2 (222) (219)
 Discarded milk (11) (16) (14)
 Veterinary service (75) (75) (75)
 Labor (40) (40) (40)
 Death loss (160) (131) (141)
Indirect cost of displaced abomasum    
 Future milk production losses (56) (56) (56)
 Future culling losses (210) (92) (133)
 Reproduction losses (29) (29) (29)
Total (792) (661) (707)
1LACT = lactation.
2Parentheses denote a negative value.
Table 8. Estimated component cost per case of metritis (totals may differ from sum of costs due to rounding) 
Item ($)
Cost per case,  
LACT1 = 1
Cost per case,  
LACT >1
Average cost  
per case
Direct cost of metritis    
 Diagnostic 0 0 0
 Therapeutic (67)2 (83) (75)
 Discarded milk (3) (6) (5)
 Veterinary service 0 0 0
 Labor (10) (12) (11)
 Death loss (20) (36) (28)
Indirect cost of metritis    
 Future milk production losses (109) (109) (109)
 Future culling losses (28) (10) (18)
 Reproduction losses (150) (150) (150)
Total (386) (405) (396)
1LACT = lactation.
2Parentheses denote a negative value.
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case of HYK (diagnosed based on a serum BHBA ≥1.4 
mmol/L or milk acetoacetic acid ≥100 μmol) to be $78 
when accounting for milk losses extending for 2 wk 
postdiagnosis, a 2-wk extended calving-to-conception 
interval, and a 3-fold increased risk of DA and clinical 
ketosis. The focus of these previous reports was not on 
the economics of HYK but rather to roughly estimate 
the losses resulting from HYK. In addition, research 
over the last decade has provided more quantifiable re-
sults regarding risk of disease occurrence as well as pro-
duction and reproduction losses associated with HYK. 
For these reasons, the estimates of the cost of HYK 
from the previously mentioned reports may underes-
timate the true cost per case. The reported total cost 
of $289 per case of HYK may similarly be a conserva-
tive estimate, as mastitis and other infectious diseases 
were not included in the model even though HYK is 
associated with immune dysfunction (Suriyasathaporn 
et al., 2000; Zarrin et al., 2014a; Zarrin et al., 2014b). 
However, the lack of current literature linking HYK, 
immune function, and incidence of infectious diseases 
in early lactation precludes inclusion of these diseases 
in the model.
Herd disease incidence had an effect on the total cost 
per case of HYK (Figure 2). A 50% increase or decrease 
in herd DA incidence changed the average total cost 
Table 9. Estimated total cost per case of hyperketonemia (blood BHBA ≥1.2 mmol/L) in early lactation dairy 
cattle (totals may differ from sum of costs due to rounding) 
Item ($, unless otherwise noted)
Cost per case,  
LACT1 = 1
Cost per case,  
LACT >1
Average cost  
per case
Component cost of hyperketonemia    
 Direct cost of hyperketonemia    
  Diagnostic (1)2 (1) (1)
  Therapeutic (3) (3) (3)
  Discarded milk 0 0 0
  Veterinary service 0 0 0
  Labor (2) (2) (2)
  Death loss (36) (29) (31)
 Indirect cost of hyperketonemia    
  Future milk production losses (30) (30) (30)
  Future culling losses (19) (5) (9)
  Reproduction losses (41) (39) (40)
 Total (134) (111) (117)
 Total cost per case (%) 36 44 41
DA3 costs attributable to hyperketonemia    
 Direct cost of DA    
  Diagnostic 0 0 0
  Therapeutic (27) (23) (24)
  Discarded milk (1) (2) (2)
  Veterinary service (10) (8) (8)
  Labor (5) (4) (4)
  Death loss (20) (13) (15)
 Indirect cost of DA    
  Future milk production losses (7) (6) (6)
  Future culling losses (27) (9) (14)
  Reproduction losses (4) (3) (3)
 Total (101) (67) (76)
 Total cost per case (%) 27 26 26
Metritis costs attributable to hyperketonemia    
 Direct cost of metritis    
  Diagnostic 0 0 0
  Therapeutic (24) (16) (18)
  Discarded milk (1) (1) (1)
  Veterinary service 0 0 0
  Labor (4) (2) (3)
  Death loss (7) (7) (7)
 Indirect cost of metritis    
  Future milk production losses (40) (20) (26)
  Future culling losses (10) (2) (4)
  Reproduction losses (55) (29) (36)
 Total (141) (77) (95)
 Total cost per case (%) 37 30 33
Total cost per case of hyperketonemia (375) (256) (289)
1LACT = lactation.
2Parentheses denote a negative value.
3DA = displaced abomasum.
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by 13% in each respective direction. Similarly, a 50% 
change in herd metritis incidence changed the average 
total cost by 16%. As the costs attributable to metri-
tis comprised a larger percentage of the total cost of 
HYK than those attributable to DA, it follows that the 
change in metritis incidence had a larger effect on the 
total cost of HYK than the change in DA incidence, 
assuming typical expected ranges of each disease in a 
herd. Although a 50% decrease in the DA or metritis 
incidence on a dairy would be significant at a herd dis-
ease level, the total cost per case of HYK still remains 
a large economic factor.
It is important to note that as herd incidence of HYK 
changed, the total cost per case of HYK remained un-
changed. This is due to the fact that as HYK incidence 
increased, the number of DA and metritis cases propor-
tionally increased, resulting in the same average cost 
per case of HYK. If this symbiosis was ignored and 
the incidence of HYK varied while the incidences of 
DA and metritis kept constant, then the average total 
cost per case of HYK at a herd incidence of 16, 32, 
and 48% was $357, $289, and $248, respectively. In real 
herds from which the published RR used in the current 
model were derived, this dissociation did not occur; as 
HYK incidence increased or decreased, DA and metritis 
incidences responded accordingly.
Each 20% reduction in the price of milk, feed price, 
and market cow price resulted in a 13% decrease, 5% 
increase, and 5% increase, respectively, in the average 
cost per case of HYK (Figure 3). Intuitively, as the 
price of milk decreased, the financial effect of future 
milk production losses decreased. Although a 40% 
reduction in the price of milk decreased the average 
total cost per case of HYK by over 25%, the resulting 
estimate of $210 per case is still a large financial burden 
considering the high incidence of HYK in many herds. 
Whereas an increase in the average cost per case of 
HYK was noted as the price of feed decreased (and thus 
the value of marginal milk increased) and similarly as 
the market cow price decreased (which increased the 
economic effect of future culling losses), this increase 
was not substantial and suggests these inputs do not 
have a large effect on the total cost of HYK.
Based on an estimated $289 total cost per case of 
HYK for a herd with 1,000 calvings per year, a DA 
incidence of 5%, a metritis incidence of approximately 
20%, and an HYK incidence of 32%, the total cost 
of HYK approaches $90,000 per year. As most HYK 
cases are subclinical in nature (McArt et al., 2013), the 
majority of these costs are unobserved. This reinforces 
the importance of proper nutritional and environmental 
management of dairy cows throughout the transition 
Figure 2. Bar chart showing the effect of herd disease incidence of displaced abomasum (DA) and metritis on the average total cost per case 
of hyperketonemia while all other inputs remain constant.
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period to decrease the incidence of HYK and its subse-
quent negative health and production effects.
CONCLUSIONS
The average total cost per case of HYK across par-
ity groups was estimated to be $289 when accounting 
for the costs associated with HYK and subsequent 
attributable metritis and DA development. Financial 
losses were almost 50% higher in primiparous versus 
multiparous cows due to an increase in costs associ-
ated with death loss and future production, culling, and 
reproductive losses.
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